Header cover image
  • Investing Ideas
  • /
  • Chinese Pharmaceuticals & Biotech Large Cap High Growth Potential

Chinese Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

3

2 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

3 companies

Beijing Wantai Biological Pharmacy Enterprise

Market Cap: CN¥76.5b

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

603392

CN¥60.49

7D

6.6%

1Y

-13.8%

CSPC Innovation Pharmaceutical

Market Cap: CN¥74.6b

Engages in the research and development, production, and sales of biopharmaceuticals, APIs, and functional foods in China and internationally.

New

300765

CN¥53.55

7D

9.6%

1Y

123.5%

Sichuan Biokin PharmaceuticalLtd

Market Cap: CN¥136.3b

Engages in the research and development, production, and marketing of small molecule chemical, molecular biological, and antibody-drug conjugate drugs in China and internationally.

New

688506

CN¥340.00

7D

8.6%

1Y

97.7%